Stereotactic body radiation therapy on abdominal-pelvic lymph node oligometastases: a systematic review on toxicity.

ABSTRACT:

Background and purpose

To review available data on toxicity during and/or after treatment of abdominal-pelvic lymph node oligometastases (A-P LN) with stereotactic body radiation therapy (SBRT) and to provide an overview of adverse events and its relation to dose or fractionation.

Material and methods

For this systematic review, we searched MEDLINE, Embase, Web of Science Core Collection, and CINAH for studies published between the database inception and October 3rd, 2023. Inclusion criteria were (1) patients with 1-5 A-P LN oligometastases, (2) treatment with SBRT to a median prescribed dose of ≥55 Gy BED10, and (3) description of acute and/or late toxicity. There were no language or date restrictions.

Results

A total of 35 studies, including 1,512 patients, were sel

SUBMITTER: Van Werkhoven LA 

PROVIDER: S-EPMC11541805 | biostudies-literature | 2024 Oct

REPOSITORIES: biostudies-literature